Cabaletta Bio Inc. has appointed Gwendolyn Binder, Ph.D., as Executive Vice President, Science & Technology. In this role, Dr. Binder will lead product research as well as all aspects of manufacturing innovation and operations for the Company. Dr. Binder will transition from her current role as a member of the Cabaletta Bio Scientific Advisory Board on February 1, 2019. Most recently, Dr. Binder served as Chief Technology Officer at Adaptimmune.